These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

268 related items for PubMed ID: 426056

  • 1. Effects of selective insulin or glucagon deficiency on glucose turnover.
    Lickley HL, Ross GG, Vranic M.
    Am J Physiol; 1979 Mar; 236(3):E255-62. PubMed ID: 426056
    [Abstract] [Full Text] [Related]

  • 2. Extrapancreatic glucagon in control of glucose turnover in depancreatized dogs.
    Ross G, Lickley L, Vranic M.
    Am J Physiol; 1978 Feb; 234(2):E213-19. PubMed ID: 623297
    [Abstract] [Full Text] [Related]

  • 3. Interactions between glucagon and other counterregulatory hormones during normoglycemic and hypoglycemic exercise in dogs.
    Wasserman DH, Lickley HL, Vranic M.
    J Clin Invest; 1984 Oct; 74(4):1404-13. PubMed ID: 6148356
    [Abstract] [Full Text] [Related]

  • 4. The essentiality of insulin and the role of glucagon in regulating glucose utilization and production during strenuous exercise in dogs.
    Vranic M, Kawamori R, Pek S, Kovacevic N, Wrenshall GA.
    J Clin Invest; 1976 Feb; 57(2):245-55. PubMed ID: 1254723
    [Abstract] [Full Text] [Related]

  • 5. Glucagon suppression improves glucoregulation in moderate but not chronic severe diabetes.
    Lickley HL, Kemmer FW, Doi K, Vranic M.
    Am J Physiol; 1983 Oct; 245(4):E424-9. PubMed ID: 6137957
    [Abstract] [Full Text] [Related]

  • 6. Important role of glucagon during exercise in diabetic dogs.
    Wasserman DH, Lickley HL, Vranic M.
    J Appl Physiol (1985); 1985 Oct; 59(4):1272-81. PubMed ID: 2865245
    [Abstract] [Full Text] [Related]

  • 7. State of metabolic control determines role of epinephrine-glucagon interaction in glucoregulation in diabetes.
    Kemmer FW, Lickley HL, Gray DE, Perez G, Vranic M.
    Am J Physiol; 1982 Jun; 242(6):E428-36. PubMed ID: 6124126
    [Abstract] [Full Text] [Related]

  • 8. Importance of glucagon in the control of futile cycling as studied in alloxan-diabetic dogs.
    Lickley HL, Kemmer FW, el-Tayeb KM, Vranic M.
    Diabetologia; 1987 Mar; 30(3):175-82. PubMed ID: 2884159
    [Abstract] [Full Text] [Related]

  • 9. Role of beta-adrenergic mechanisms during exercise in poorly controlled diabetes.
    Wasserman DH, Lickley HL, Vranic M.
    J Appl Physiol (1985); 1985 Oct; 59(4):1282-9. PubMed ID: 2865246
    [Abstract] [Full Text] [Related]

  • 10. Changes in glucagon do not play an essential role in the glucoregulatory responses to mild hyperinsulinemia in dogs.
    Werther GA, Banach W, Joffe S, Artal R, Sperling MA.
    Diabetes Res Clin Pract; 1987 Oct; 3(1):55-61. PubMed ID: 2880702
    [Abstract] [Full Text] [Related]

  • 11. The effect of somatostatin on epinephrine-induced free fatty acid release in normal man.
    Botha JL, Vinik AI, Child P, Lund A, van Tonder S.
    S Afr Med J; 1977 Dec 10; 52(25):995-7. PubMed ID: 607511
    [Abstract] [Full Text] [Related]

  • 12. Exercise-induced fall in insulin: mechanism of action at the liver and effects on muscle glucose metabolism.
    Zinker BA, Mohr T, Kelly P, Namdaran K, Bracy DP, Wasserman DH.
    Am J Physiol; 1994 May 10; 266(5 Pt 1):E683-9. PubMed ID: 7911275
    [Abstract] [Full Text] [Related]

  • 13. Impact of insulin deficiency on glucose fluxes and muscle glucose metabolism during exercise.
    Wasserman DH, Mohr T, Kelly P, Lacy DB, Bracy D.
    Diabetes; 1992 Oct 10; 41(10):1229-38. PubMed ID: 1356861
    [Abstract] [Full Text] [Related]

  • 14. A-Cell and gut glucagon in normal and depancreatized dogs. Inhibition by somatostatin and insulin.
    Matsuyama T, Wider MD, Tanaka R, Shima K, Tarui S, Nishikawa M, Foà PP.
    Diabete Metab; 1979 Jun 10; 5(2):141-7. PubMed ID: 478084
    [Abstract] [Full Text] [Related]

  • 15. Importance of glucagon in mediating epinephrine-induced hyperglycemia in alloxan-diabetic dogs.
    Perez G, Kemmer FW, Lickley HL, Vranic M.
    Am J Physiol; 1981 Oct 10; 241(4):E328-35. PubMed ID: 7032319
    [Abstract] [Full Text] [Related]

  • 16. Studies on the mechanism underlying the influence of alanine infusion on glucose dynamics in the dog.
    Saccà L, Trimarco B, Perez G, Rengo F.
    Diabetes; 1977 Apr 10; 26(4):262-70. PubMed ID: 300341
    [Abstract] [Full Text] [Related]

  • 17. Glucoregulatory role of cortisol and epinephrine interactions studied in adrenalectomized dogs.
    Gauthier C, el-Tayeb K, Vranic M, Lickley HL.
    Am J Physiol; 1986 Apr 10; 250(4 Pt 1):E393-401. PubMed ID: 3515964
    [Abstract] [Full Text] [Related]

  • 18. Glucose homeostasis during prolonged suppression of glucagon and insulin secretion by somatostatin.
    Sherwin RS, Hendler R, DeFronzo R, Wahren J, Felic P.
    Proc Natl Acad Sci U S A; 1977 Jan 10; 74(1):348-52. PubMed ID: 264686
    [Abstract] [Full Text] [Related]

  • 19. Metabolic effects of graded glucagon infusions in man: inhibition of glucagon, insulin, and somatostatin response to arginine.
    Pontiroli AE, Perfetti MG, Andreotti AC, Fattor B, Monti LD, Pozza G.
    Metabolism; 1993 Oct 10; 42(10):1242-8. PubMed ID: 8105365
    [Abstract] [Full Text] [Related]

  • 20. Prostaglandin synthesis inhibitors impair hepatic glucose production in response to glucagon and epinephrine stimulation.
    Miller JD, Ganguli S, Sperling MA.
    Diabetes; 1983 May 10; 32(5):439-44. PubMed ID: 6301913
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.